Incidence of cutaneous adverse events after exposure to tenofovir–emtricitabine in HIV-uninfected vs HIV-infected patients: pharmacovigilance within a large Midwestern U.S. patient population from the Research on Adverse Drug events And Reports program

C. Kosche, A. Para, J. Brieva, D. P. West, F. J. Palella, B. Nardone*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'Incidence of cutaneous adverse events after exposure to tenofovir–emtricitabine in HIV-uninfected vs HIV-infected patients: pharmacovigilance within a large Midwestern U.S. patient population from the Research on Adverse Drug events And Reports program'. Together they form a unique fingerprint.